Contact
Please use this form to send email to PR contact of this press release:
CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with Bionpharma Inc.
TO:
Mark DaFonseca
CoreRx, Inc.
+1 727-259-6950